When metabolic disease rewrites infection biology: Long-term multiorgan consequences of Helicobacter pylori infection in diabetes

Table 1 Summary of key experimental findings in Yang et al[1] and their mechanistic and clinical interpretation

Experimental domain	Key finding	Proposed mechanism	Clinical implication
Gastric colonization	Prolonged H. pylori persistence in diabetic mice vs controls	Hyperglycemia impairs mucosal immunity, Th1/Th17 responses, and antimicrobial peptide expression	Diabetic patients may require extended or repeated eradication regimens
Gastric histopathology	Progressive submucosal inflammation and fibrosis; irreversible gastritis	Sustained IL-6, TNF-α, IL-1β release; oxidative stress-driven fibrogenesis	Early eradication essential before irreversible mucosal remodelling
Hepatic virulence factor detection	CagA and other virulence proteins detected in liver tissue	Exosome-mediated systemic CagA delivery; intestinal barrier disruption facilitating portal translocation	H. pylori may contribute to NAFLD/NASH progression in diabetic hosts
Gut microbiota	Compounded dysbiosis; delayed microbial recovery even after bacterial decline	Synergistic disruption of microbial ecology and colonization resistance by H. pylori plus diabetes	Microbiota-targeted adjunctive therapy (probiotics/prebiotics) may benefit diabetic H. pylori patients
Apoptosis profile	Widespread apoptosis across stomach, pancreas, liver, and kidney	Convergence of metabolic stress, immune activation, and pathogen-derived pro-apoptotic signals	Organ function monitoring warranted even after eradication in long-standing diabetic infection
Temporal dissociation	Tissue injury persists despite declining bacterial burden and partial glycemic recovery	Inflammatory memory and self-sustaining cytokine loops operating independently of active infection	Microbiological eradication does not equal biological resolution; post-eradication surveillance is essential

NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; TNF-α: Tumour necrosis factor-alpha; H. pylori: Helicobacter pylori; IL-6: Interleukin-6; IL-1β: Interleukin-1 beta; CagA: Cytotoxin-associated gene A.